Hemangioma of the maxilla

Treatment of maxillary hemangioma with a sclerosing agent

This article reports the case of a patient with a reasonably large maxillary hemangioma involving bone and overlying mucosa. A dramatic shrinkage of the lesion over a 4-week period was noted when sodium morrhuate was used as the sclerosing agent. Four and one half years following therapy, no recurrence of the tumor was noted. Radiographically, the area of involvement had become significantly more dense, with an increase in size and calcification of phleboliths in the area.

Central hemangioma of the maxilla

A case of central maxillary hemangioma is reported in which the only clinical symptom was spontaneous, recurrent, gingival papillary bleeding between the maxillary left premolars. The radiographic findings were inconclusive. It is strongly recommended that in cases where this diagnosis is suspected, surgical intervention be carried out under optimal conditions in an operating theater under hypotensive general anesthesia and with an ample supply of whole blood available.

Hemangioma of maxilla

Bony hemangiomas, while occurring with some frequency in the axial skeleton, are rare in the maxilla. A case is described bring the total in the world literature to 12. Presenting symptoms and signs can include a pulsatile cheek mass, bruit, and toothache. If conventional x-ray reveals a honeycomb effect and resorption of bone, angiography may establish the diagnosis preoperatively. Maxillectomy is probably the treatment of choice. Biopsy is fraught with danger, and should only be undertaken at the time of definitive surgery.